1-12 of 12
Mark A. Socinski
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Circulating Tumor DNA Monitoring on Chemo-immunotherapy for Risk Stratification in Advanced Non–Small Cell Lung Cancer

Open Access
Bruna Pellini, Russell W. Madison, Merrida A. Childress, Shoshana T. Miller, Ole Gjoerup, Jason Cheng, Richard S.P. Huang, Michael Krainock, Pratyush Gupta, Wei Zou, David S. Shames, Solomon Moshkevich, Marcus Ballinger, Minetta C. Liu, Amanda Young, Minu K. Srivastava, Geoffrey R. Oxnard, Mark A. Socinski
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (22): 4596–4605.
https://doi.org/10.1158/1078-0432.CCR-23-1578
Published: 14 November 2023
View articletitled, Circulating Tumor DNA Monitoring on Chemo-immunotherapy for Risk Stratification in Advanced Non–Small Cell Lung Cancer
Open the PDF for Circulating Tumor DNA Monitoring on Chemo-immunotherapy for Risk Stratification in Advanced Non–Small Cell Lung Cancer in another window
Includes: Supplementary data
Journal Articles

Correction: Tumor Dynamic Model-Based Decision Support for Phase Ib/II Combination Studies: A Retrospective Assessment Based on Resampling of the Phase III Study IMpower150

Free
René Bruno, Mathilde Marchand, Kenta Yoshida, Phyllis Chan, Haocheng Li, Wei Zou, Francois Mercier, Pascal Chanu, Benjamin Wu, Anthony Lee, Chunze Li, Jin Y. Jin, Michael L. Maitland, Martin Reck, Mark A. Socinski
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (20): 4314.
https://doi.org/10.1158/1078-0432.CCR-23-2525
Published: 13 October 2023
View articletitled, Correction: Tumor Dynamic Model-Based Decision Support for Phase Ib/II Combination Studies: A Retrospective Assessment Based on Resampling of the Phase III Study IMpower150
Open the PDF for Correction: Tumor Dynamic Model-Based Decision Support for Phase Ib/II Combination Studies: A Retrospective Assessment Based on Resampling of the Phase III Study IMpower150 in another window
Journal Articles

Tumor Dynamic Model-Based Decision Support for Phase Ib/II Combination Studies: A Retrospective Assessment Based on Resampling of the Phase III Study IMpower150

Available to Purchase
René Bruno, Mathilde Marchand, Kenta Yoshida, Phyllis Chan, Haocheng Li, Wei Zou, Francois Mercier, Pascal Chanu, Benjamin Wu, Anthony Lee, Chunze Li, Jin Y. Jin, Michael L. Maitland, Martin Reck, Mark A. Socinski
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (6): 1047–1055.
https://doi.org/10.1158/1078-0432.CCR-22-2323
Published: 14 March 2023
View articletitled, Tumor Dynamic Model-Based Decision Support for Phase Ib/II Combination Studies: A Retrospective Assessment Based on Resampling of the Phase III Study IMpower150
Open the PDF for Tumor Dynamic Model-Based Decision Support for Phase Ib/II Combination Studies: A Retrospective Assessment Based on Resampling of the Phase III Study IMpower150 in another window
Includes: Supplementary data
Journal Articles

Phase II Study of the AKT Inhibitor MK-2206 plus Erlotinib in Patients with Advanced Non–Small Cell Lung Cancer Who Previously Progressed on Erlotinib

Free
Primo N. Lara, Jr, Jeff Longmate, Philip C. Mack, Karen Kelly, Mark A. Socinski, Ravi Salgia, Barbara Gitlitz, Tianhong Li, Mariana Koczywas, Karen L. Reckamp, David R. Gandara
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (19): 4321–4326.
https://doi.org/10.1158/1078-0432.CCR-14-3281
Published: 30 September 2015
View articletitled, Phase II Study of the AKT Inhibitor MK-2206 plus Erlotinib in Patients with Advanced Non–Small Cell Lung Cancer Who Previously Progressed on Erlotinib
Open the PDF for Phase II Study of the AKT Inhibitor MK-2206 plus Erlotinib in Patients with Advanced Non–Small Cell Lung Cancer Who Previously Progressed on Erlotinib in another window
Journal Articles

A Multicenter Phase II Study of Ganetespib Monotherapy in Patients with Genotypically Defined Advanced Non–Small Cell Lung Cancer

Free
Mark A. Socinski, Jonathan Goldman, Iman El-Hariry, Marianna Koczywas, Vojo Vukovic, Leora Horn, Eugene Paschold, Ravi Salgia, Howard West, Lecia V. Sequist, Philip Bonomi, Julie Brahmer, Lin-Chi Chen, Alan Sandler, Chandra P. Belani, Timothy Webb, Harry Harper, Mark Huberman, Suresh Ramalingam, Kwok-Kin Wong, Florentina Teofilovici, Wei Guo, Geoffrey I. Shapiro
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (11): 3068–3077.
https://doi.org/10.1158/1078-0432.CCR-12-3381
Published: 30 May 2013
View articletitled, A Multicenter Phase II Study of Ganetespib Monotherapy in Patients with Genotypically Defined Advanced Non–Small Cell Lung Cancer
Open the PDF for A Multicenter Phase II Study of Ganetespib Monotherapy in Patients with Genotypically Defined Advanced Non–Small Cell Lung Cancer in another window
Includes: Supplementary data
Journal Articles

The Clinical Viewpoint: Definitions, Limitations of RECIST, Practical Considerations of Measurement

Free
Liza C. Villaruz, Mark A. Socinski
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (10): 2629–2636.
https://doi.org/10.1158/1078-0432.CCR-12-2935
Published: 12 May 2013
View articletitled, The Clinical Viewpoint: Definitions, Limitations of RECIST, Practical Considerations of Measurement
Open the PDF for The Clinical Viewpoint: Definitions, Limitations of RECIST, Practical Considerations of Measurement in another window
Journal Articles

Lung Squamous Cell Carcinoma mRNA Expression Subtypes Are Reproducible, Clinically Important, and Correspond to Normal Cell Types

Free
Matthew D. Wilkerson, Xiaoying Yin, Katherine A. Hoadley, Yufeng Liu, Michele C. Hayward, Christopher R. Cabanski, Kenneth Muldrew, C. Ryan Miller, Scott H. Randell, Mark A. Socinski, Alden M. Parsons, William K. Funkhouser, Carrie B. Lee, Patrick J. Roberts, Leigh Thorne, Philip S. Bernard, Charles M. Perou, D. Neil Hayes
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (19): 4864–4875.
https://doi.org/10.1158/1078-0432.CCR-10-0199
Published: 29 September 2010
View articletitled, Lung Squamous Cell Carcinoma mRNA Expression Subtypes Are Reproducible, Clinically Important, and Correspond to Normal Cell Types
Open the PDF for Lung Squamous Cell Carcinoma mRNA Expression Subtypes Are Reproducible, Clinically Important, and Correspond to Normal Cell Types in another window
Includes: Supplementary data
Journal Articles

Antibodies to the Epidermal Growth Factor Receptor in Non–Small Cell Lung Cancer: Current Status of Matuzumab and Panitumumab

Free
Mark A. Socinski
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (15): 4597s–4601s.
https://doi.org/10.1158/1078-0432.CCR-07-0335
Published: 01 August 2007
View articletitled, Antibodies to the Epidermal Growth Factor Receptor in Non–Small Cell Lung Cancer: Current Status of Matuzumab and Panitumumab
Open the PDF for Antibodies to the Epidermal Growth Factor Receptor in Non–Small Cell Lung Cancer: Current Status of Matuzumab and Panitumumab in another window
Journal Articles

Novel Agents in the Treatment of Lung Cancer: Fourth Cambridge Conference

Free
Thomas J. Lynch, Philip D. Bonomi, Charles Butts, Angela M. Davies, Jeffrey Engelman, Ramaswamy Govindan, Roy S. Herbst, John V. Heymach, Bruce E. Johnson, Renato G. Martins, Roman Perez-Soler, Gregory J. Riely, Alan B. Sandler, Lecia V. Sequist, Mark A. Socinski, Kwok-Kin Wong, Carol S. Hart
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (15): 4583s–4588s.
https://doi.org/10.1158/1078-0432.CCR-07-0716
Published: 01 August 2007
View articletitled, Novel Agents in the Treatment of Lung Cancer: Fourth Cambridge Conference
Open the PDF for Novel Agents in the Treatment of Lung Cancer: Fourth Cambridge Conference in another window
Journal Articles

Concurrent Chemoradiotherapy for Unresectable Stage III Non–Small Cell Lung Cancer

Free
Everett E. Vokes, Jeffrey Crawford, Jeffrey Bogart, Mark A. Socinski, Gerald Clamon, Mark R. Green
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (13): 5045s–5050s.
https://doi.org/10.1158/1078-0432.CCR-05-9008
Published: 06 July 2005
View articletitled, Concurrent Chemoradiotherapy for Unresectable Stage III Non–Small Cell Lung Cancer
Open the PDF for Concurrent Chemoradiotherapy for Unresectable Stage III Non–Small Cell Lung Cancer in another window
Journal Articles

Cytotoxic Chemotherapy in Advanced Non-Small Cell Lung Cancer: A Review of Standard Treatment Paradigms

Free
Mark A. Socinski
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (12): 4210s–4214s.
https://doi.org/10.1158/1078-0432.CCR-040009
Published: 15 June 2004
View articletitled, Cytotoxic Chemotherapy in Advanced Non-Small Cell Lung Cancer: A Review of Standard Treatment Paradigms
Open the PDF for Cytotoxic Chemotherapy in Advanced Non-Small Cell Lung Cancer: A Review of Standard Treatment Paradigms in another window
Journal Articles

Novel Agents in the Treatment of Lung Cancer: Conference Summary Statement

Free
Thomas J. Lynch, Alex A. Adjei, Paul A. Bunn, Jr., Raymond N. DuBois, David R. Gandara, Giuseppe Giaccone, Ramaswamy Govindan, Roy S. Herbst, Bruce E. Johnson, Fadlo R. Khuri, Roman Perez-Soler, Rafael Rosell, Eric K. Rowinsky, Alan B. Sandler, Giorgio V. Scagliotti, Joan H. Schiller, Geoffrey I. Shapiro, Mark A. Socinski, Carol S. Hart
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (12): 4199s–4204s.
https://doi.org/10.1158/1078-0432.CCR-040021
Published: 15 June 2004
View articletitled, Novel Agents in the Treatment of Lung Cancer: Conference Summary Statement
Open the PDF for Novel Agents in the Treatment of Lung Cancer: Conference Summary Statement in another window